AhR Antagonist Promotes Differentiation of Papillary Thyroid Cancer via Regulating circSH2B3/miR-4640-5P/IGF2BP2 Axis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AhR Antagonist Promotes Differentiation of Papillary Thyroid Cancer via Regulating circSH2B3/miR-4640-5P/IGF2BP2 Axis
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-24
DOI
10.3389/fphar.2021.795386
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circular RNA circRUNX1 promotes papillary thyroid cancer progression and metastasis by sponging MiR-296-3p and regulating DDHD2 expression
- (2021) Junjie Chu et al. Cell Death & Disease
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- LncRNA OGFRP1 acts as an oncogene in NSCLC via miR-4640-5p/eIF5A axis
- (2021) Xiaojing Liu et al. Cancer Cell International
- IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR
- (2021) Liangpeng Dong et al. PATHOLOGY RESEARCH AND PRACTICE
- Translation and functional roles of circular RNAs in human cancer
- (2020) Ming Lei et al. Molecular Cancer
- A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid Cancer
- (2020) Ji Min Oh et al. THYROID
- Circular RNA Profiling Reveals Exosomal circ_0006156 as a Novel Biomarker in Papillary Thyroid Cancer
- (2020) Guojun Wu et al. Molecular Therapy-Nucleic Acids
- The Aryl Hydrocarbon Receptor Is Expressed in Thyroid Carcinoma and Appears to Mediate Epithelial-Mesenchymal-Transition
- (2020) Sonia Moretti et al. Cancers
- Identification and validation of m6A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer
- (2020) Xinyi Wang et al. Cancer Cell International
- Redifferentiation of radioiodine-refractory thyroid cancers
- (2020) Camille Buffet et al. ENDOCRINE-RELATED CANCER
- Circular RNA DOCK1 downregulates microRNA ‐124 to induce the growth of human thyroid cancer cell lines
- (2020) Wei Cui et al. BIOFACTORS
- Diminished AHR signaling drives human acute myeloid leukemia stem cell maintenance
- (2019) Michelle Ly et al. CANCER RESEARCH
- Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma
- (2019) Hui Zhao et al. Journal of Translational Medicine
- The biogenesis, biology and characterization of circular RNAs
- (2019) Lasse S. Kristensen et al. NATURE REVIEWS GENETICS
- IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader
- (2019) Xiaoge Hu et al. CELL DEATH AND DIFFERENTIATION
- Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway
- (2019) Xiaodong Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Roles of Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 in Cancer and Cancer Stem Cells
- (2018) Junguo Cao et al. Stem Cells International
- Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma
- (2018) Sébastien Corre et al. Nature Communications
- CircRNA: functions and properties of a novel potential biomarker for cancer
- (2017) Shujuan Meng et al. Molecular Cancer
- Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer
- (2016) Byeong-Cheol Ahn Biomed Research International
- Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiation
- (2015) S Jang et al. CANCER GENE THERAPY
- Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
- (2012) Jessica L. Bell et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Ah Receptor Antagonism Represses Head and Neck Tumor Cell Aggressive Phenotype
- (2012) B. C. DiNatale et al. MOLECULAR CANCER RESEARCH
- Activation of the Aryl Hydrocarbon Receptor AhR Promotes Retinoic Acid-Induced Differentiation of Myeloblastic Leukemia Cells by Restricting Expression of the Stem Cell Transcription Factor Oct4
- (2011) R. P. Bunaciu et al. CANCER RESEARCH
- Ah receptor antagonism inhibits constitutive and cytokine inducible IL6 production in head and neck tumor cell lines
- (2010) Brett C. DiNatale et al. MOLECULAR CARCINOGENESIS
- The widespread regulation of microRNA biogenesis, function and decay
- (2010) Jacek Krol et al. NATURE REVIEWS GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started